Evidence map›Paper›PMID 24813724›Full record

ArticleMicrocirculation (New York, N.Y. : 1994)2014

Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.

Jharon N Silva, Oksana Polesskaya, Helen S Wei, Izad-Yar D Rasheed, Jeffrey M Chamberlain, Christopher Nishimura, Changyong Feng, Stephen Dewhurst

Open access · greenAbstract read
In one paragraph

Article in Microcirculation (New York, N.Y. : 1994), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jharon N SilvaDepartments of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
Oksana Polesskaya
Helen S Wei
Izad-Yar D Rasheed
Jeffrey M Chamberlain
Christopher Nishimura
Changyong Feng
Stephen Dewhurst
University of Rochester Medical Center · USNorthwestern University · US

Funding

University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
Cerebrovascular mechanisms in methamphetamine-mediated exacerbation of neuroAIDSR01DA026325 · NIDA · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2012
$1.7M
Howard Hughes Medical InstituteNIAID NIH HHS P30 AI078498NIAID NIH HHS P30AI078498NIDA NIH HHS R01 DA026325NIDA NIH HHS R01DA026325NIGMS NIH HHS T32 GM007356NIGMS NIH HHS T32GM007356
6 · The paper itself

Abstract

objectivesHIV-1 infection of the CNS is associated with impairment of CBF and neurocognitive function, and accelerated signs of aging. As normal aging is associated with rarefaction of the cerebral vasculature, we set out to examine chronic viral effects on the cerebral vasculature.

methodsDOX-inducible HIV-1 Tat-tg and WT control mice were used. Animals were treated with DOX for three weeks or five to seven months. Cerebral vessel density and capillary segment length were determined from quantitative image analyses of sectioned cortical tissue. In addition, movement of red blood cells in individual capillaries was imaged in vivo using multiphoton microscopy, to determine RBCV and flux.

resultsMean RBCV was not different between Tat-tg mice and age-matched WT controls. However, cortical capillaries from Tat-tg mice showed a significant loss of RBCV heterogeneity and increased RBCF that was attributed to a marked decrease in total cortical capillary length (35-40%) compared to WT mice.

conclusionsCerebrovascular rarefaction is accelerated in HIV-1 Tat-transgenic mice, and this is associated with alterations in red cell blood velocity. These changes may have relevance to the pathogenesis of HIV-associated neurocognitive disorders in an aging HIV-positive population.

Indexed as

Blood Flow VelocityGenes, tatAnimalsAstrocytesCapillariesDoxycyclineErythrocyte IndicesHemodynamicsHIV-1MaleMiceMice, TransgenicMicroscopy, Fluorescence, MultiphotonNeocortexNeovascularization, PhysiologicPyramidal CellsDoxycyclineRecombinant Fusion Proteinstat Gene Products, Human Immunodeficiency Viruscapillary rarefactioncerebrovascularHIV-1red blood cell velocityTat-transgenic mice

Identifiers

PMID24813724
PMCPMC4194156
OpenAlexW1993264923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.